Cargando…

Progress in the elimination of hepatitis C virus infection: A population-based cohort study in Spain

BACKGROUND: The World Health Organization set targets to eliminate hepatitis C virus (HCV) infection through detection and treatment of all cases by 2030. This study aimed to describe the progress and difficulties in the elimination of HCV infection in Navarra, Spain. METHODS: Using electronic healt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Juanbeltz, Regina, Pérez-García, Alejandra, Aguinaga, Aitziber, Martínez-Baz, Iván, Casado, Itziar, Burgui, Cristina, Goñi-Esarte, Silvia, Repáraz, Jesús, Zozaya, José Manuel, San Miguel, Ramón, Ezpeleta, Carmen, Castilla, Jesús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279228/ https://www.ncbi.nlm.nih.gov/pubmed/30513107 http://dx.doi.org/10.1371/journal.pone.0208554

Ejemplares similares

Detection of Respiratory Viruses in Deceased Persons, Spain, 2017
por: Navascués, Ana, et al.
Publicado: (2018)

Interim effectiveness of trivalent influenza vaccine in a season dominated by lineage mismatched influenza B, northern Spain, 2017/18
por: Castilla, Jesús, et al.
Publicado: (2018)

Impact of successful treatment with direct-acting antiviral agents on health-related quality of life in chronic hepatitis C patients
por: Juanbeltz, Regina, et al.
Publicado: (2018)

Simple models to include influenza vaccination history when evaluating the effect of influenza vaccination
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Combined effectiveness of prior and current season influenza vaccination in northern Spain: 2016/17 mid-season analysis
por: Castilla, Jesús, et al.
Publicado: (2017)

Comparison of influenza vaccine effectiveness in preventing outpatient and inpatient influenza cases in older adults, northern Spain, 2010/11 to 2015/16
por: Castilla, Jesús, et al.
Publicado: (2018)

Trends and causes of mortality in a population-based cohort of HIV-infected adults in Spain: comparison with the general population
por: Fontela, Carmen, et al.
Publicado: (2020)

Influenza Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Cases and Hospitalizations in Navarre, Spain, 2022–2023
por: Martínez-Baz, Iván, et al.
Publicado: (2023)

Seroprevalence of antibodies against SARS-CoV-2 and risk of COVID-19 in Navarre, Spain, May to July 2022
por: Castilla, Jesús, et al.
Publicado: (2022)

Effectiveness of influenza vaccination in preventing influenza in primary care, Navarre, Spain, 2021/22
por: Martínez-Baz, Iván, et al.
Publicado: (2022)

Household Transmission of Influenza A(H1N1)pdm09 in the Pandemic and Post-Pandemic Seasons
por: Casado, Itziar, et al.
Publicado: (2014)

Effect of influenza vaccination in patients with asthma
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Effect of COVID-19 vaccination on the SARS-CoV-2 transmission among social and household close contacts: A cohort study
por: Martínez-Baz, Iván, et al.
Publicado: (2023)

Use of Medical Care during Pandemic (H1N1) 2009, Navarre, Spain
por: Burgui, Rosana, et al.
Publicado: (2011)

Differences in Transmission between SARS-CoV-2 Alpha (B.1.1.7) and Delta (B.1.617.2) Variants
por: Trobajo-Sanmartín, Camino, et al.
Publicado: (2022)

Infecciones, hospitalizaciones y mortalidad por COVID-19 en Navarra entre febrero de 2020 y septiembre de 2022
por: Casado, Itziar, et al.
Publicado: (2023)

Risk Factors of Infection, Hospitalization and Death from SARS-CoV-2: A Population-Based Cohort Study
por: Castilla, Jesús, et al.
Publicado: (2021)

Effectiveness of palivizumab in preventing respiratory syncytial virus infection in high-risk children
por: Viguria, Natividad, et al.
Publicado: (2021)

Chronic obstructive pulmonary disease and influenza vaccination effect in preventing outpatient and inpatient influenza cases
por: Martínez-Baz, Iván, et al.
Publicado: (2022)

Mycoplasma pneumoniae y resistencias a macrólidos: ¿Conocemos la situación en Europa?
por: Varela, Ana Isabel Álvaro, et al.
Publicado: (2023)

Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection and hospitalisation, Navarre, Spain, January to April 2021
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Hypertension and Related Comorbidities as Potential Risk Factors for COVID-19 Hospitalization and Severity: A Prospective Population-Based Cohort Study
por: Fresán, Ujué, et al.
Publicado: (2021)

Risk reduction of hospitalisation and severe disease in vaccinated COVID-19 cases during the SARS-CoV-2 variant Omicron BA.1-predominant period, Navarre, Spain, January to March 2022
por: Martínez-Baz, Iván, et al.
Publicado: (2023)

Artritis meningocócica primaria
por: Machain, Estibaliz Erviti, et al.
Publicado: (2021)

Product-specific COVID-19 vaccine effectiveness against secondary infection in close contacts, Navarre, Spain, April to August 2021
por: Martínez-Baz, Iván, et al.
Publicado: (2021)

Respiratory syncytial virus hospitalization in children in northern Spain
por: Viguria, Natividad, et al.
Publicado: (2018)

Enhanced Estimates of the Influenza Vaccination Effect in Preventing Mortality: A Prospective Cohort Study
por: Castilla, Jesús, et al.
Publicado: (2015)

Criptosporidiosis en paciente inmunodeprimida por trasplante renal
por: Garcia, Irati Arregui, et al.
Publicado: (2021)

Quality of life in people living with HIV in Romania and Spain
por: Kall, Meaghan, et al.
Publicado: (2021)

Macrolide-Resistant Mycoplasma genitalium in Southeastern Region of the Netherlands, 2014–2017
por: Adelantado, Marta, et al.
Publicado: (2019)

Influenza Vaccination and Risk of SARS-CoV-2 Infection in a Cohort of Health Workers
por: Martínez-Baz, Iván, et al.
Publicado: (2020)

Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain
por: Gherasim, Alin, et al.
Publicado: (2017)

Impact of the COVID-19 pandemic on HCV elimination in Spain
por: Buti, Maria, et al.
Publicado: (2021)

Effectiveness of the trivalent influenza vaccine in Navarre, Spain, 2010–2011: a population-based test-negative case–control study
por: Martínez-Baz, Iván, et al.
Publicado: (2013)

Clinical course of patients with severe COVID-19 pneumonia treated with remdesivir: A real-life study
por: Tejada, Diana, et al.
Publicado: (2022)

Estimation of COVID-19 vaccine effectiveness against hospitalisation in individuals aged ≥ 65 years using electronic health registries; a pilot study in four EU/EEA countries, October 2021 to March 2022
por: Sentís, Alexis, et al.
Publicado: (2022)

Emergence of SARS-CoV-2 Variant B.1.575.2, Containing the E484K Mutation in the Spike Protein, in Pamplona, Spain, May to June 2021
por: Trobajo-Sanmartín, Camino, et al.
Publicado: (2021)

The economic burden of pulmonary arterial hypertension in Spain
por: Zozaya, Néboa, et al.
Publicado: (2022)

Brain and Central Nervous System Cancer Incidence in Navarre (Spain), 1973-2008 and Projections for 2014
por: Etxeberria, J., et al.
Publicado: (2015)

Empyema caused by MRSA ST398 with Atypical Resistance Profile, Spain
por: Lozano, Carmen, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_98m6f7uujdqtiev5m9kg18o6nb